Insider Trading History of Higgins John L

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Higgins John L since 2015. This trader's CIK number is 1208906. At the time of last reporting, Higgins John L was the Director of Omniab, Inc.. (stock ticker symbol OABI). Also see all insider trading activities at Omniab, Inc..

Note that in the past HIGGINS JOHN L also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Ligand Pharmaceuticals Inc (LGND) by Higgins John L

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 LGND 0 $0 25,000 $1,849,879 38,000 $558,760
2021 LGND 0 $0 147,666 $26,830,728 234,666 $3,402,955
2020 LGND 0 $0 0 $0 87,097 $1,138,984
2019 LGND 7,850 $854,259 0 $0 33,790 $545,370
2018 LGND 0 $0 110,004 $20,921,833 44,654 $693,993
2017 LGND 0 $0 42,676 $5,206,252 54,208 $977,199
2016 LGND 0 $0 13,833 $1,464,623 6,000 $126,000
2015 LGND 0 $0 14,666 $1,452,946 0 $0

Yearly summary of insider trading at Bio-techne Corp (TECH) by Higgins John L

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 TECH 0 $0 0 $0 12,000 $262,080
2024 TECH 0 $0 4,000 $335,376 16,000 $367,200
2023 TECH 0 $0 0 $0 16,000 $349,600
2022 TECH 0 $0 1,600 $583,963 1,600 $107,040
2020 TECH 0 $0 10,000 $2,525,935 10,000 $659,050
2018 TECH 0 $0 10,000 $1,879,170 10,000 $610,800
2016 TECH 0 $0 1,700 $186,716 0 $0

Yearly summary of insider trading at Omniab, Inc. (OABI) by Higgins John L

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 OABI 194,750 $398,232 0 $0 33,172 $0
2024 OABI 0 $0 0 $0 33,173 $0
2023 OABI 0 $0 60,000 $235,000 60,000 $220,800
2022 OABI 0 $0 0 $0 246,648 $621,552


Insider trading activities at 3 companies by Higgins John L:

1. Ligand Pharmaceuticals Inc (LGND)

2. Bio-techne Corp (TECH)

3. Omniab, Inc. (OABI)

Table 1. Insider trading of Ligand Pharmaceuticals Inc (LGND) by Higgins John L

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-12-16 LGND Sale 10,000 61.87 618,660
2022-12-12 LGND Option Ex 20,000 12.78 255,600
2022-11-17 LGND Sale 10,000 78.32 783,169
2022-11-18 LGND Option Ex 10,000 12.78 127,800
2022-09-15 LGND Sale 2,000 90.00 180,000
2022-09-16 LGND Sale 3,000 89.35 268,050
2022-05-09 LGND Option Ex 8,000 21.92 175,360
2021-11-12 LGND Sale 3,000 160.50 481,500
2021-02-05 LGND Option Ex 114,666 12.26 1,405,805
2021-02-05 LGND Sale 54,666 203.40 11,119,228
2021-01-27 LGND Sale 40,000 182.00 7,280,000
2021-01-27 LGND Option Ex 70,000 18.20 1,273,650
2021-01-25 LGND Sale 50,000 159.00 7,950,000
2021-01-25 LGND Option Ex 50,000 14.47 723,500
2020-12-08 LGND Option Ex 14,657 10.05 147,302
2020-11-09 LGND Option Ex 20,000 10.05 201,000
2020-07-07 LGND Option Ex 4,315 72.16 311,357
2020-02-13 LGND Option Ex 48,125 9.96 479,325
2019-07-31 LGND Buy 1,850 95.45 176,582
2019-05-31 LGND Buy 1,000 108.20 108,202
2019-05-14 LGND Buy 2,500 113.50 283,750
2019-03-13 LGND Buy 2,500 114.29 285,725
2019-01-10 LGND Option Ex 33,790 16.14 545,370
2018-08-30 LGND Sale 3,500 258.25 903,875
2018-08-16 LGND Sale 21,507 241.33 5,190,262
2018-08-17 LGND Option Ex 12,993 14.47 188,008
2018-08-16 LGND Option Ex 3,007 14.47 43,511
2018-08-17 LGND Sale 12,993 243.00 3,157,299
2018-05-15 LGND Sale 12,405 179.97 2,232,490
2018-05-15 LGND Option Ex 12,405 16.14 200,216
2018-02-15 LGND Sale 9,000 157.03 1,413,279
2018-01-24 LGND Sale 22,500 165.00 3,712,500
2018-01-19 LGND Option Ex 16,249 16.14 262,258
2018-01-19 LGND Sale 28,099 153.46 4,312,128
2017-11-17 LGND Sale 2,258 140.34 316,887
2017-11-16 LGND Sale 5,269 142.53 750,990
2017-10-13 LGND Option Ex 11,384 21.92 249,537
2017-09-05 LGND Option Ex 5,000 21.00 105,000
2017-09-05 LGND Sale 5,000 130.00 650,000
2017-08-08 LGND Option Ex 5,483 21.00 115,143
2017-08-08 LGND Sale 5,483 125.00 685,375
2017-06-21 LGND Sale 4,666 120.00 559,920
2017-06-21 LGND Option Ex 4,666 21.00 97,986
2017-06-09 LGND Option Ex 12,000 21.00 252,000
2017-06-09 LGND Sale 12,000 114.87 1,378,440
2017-03-20 LGND Sale 4,000 109.10 436,400
2017-03-08 LGND Option Ex 15,675 10.05 157,533
2017-03-08 LGND Sale 4,000 107.06 428,240
2016-09-22 LGND Sale 3,000 117.34 352,020
2016-03-08 LGND Option Ex 6,000 21.00 126,000
2016-03-07 LGND Sale 10,833 102.70 1,112,603
2015-08-06 LGND Sale 4,666 110.79 516,946
2015-06-09 LGND Sale 10,000 93.60 936,000

Table 2. Insider trading of Bio-techne Corp (TECH) by Higgins John L

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-05-01 TECH Option Ex 12,000 21.84 262,080
2024-09-12 TECH Option Ex 6,000 22.95 137,700
2024-07-08 TECH Option Ex 6,000 22.95 137,700
2024-05-14 TECH Sale 4,000 83.84 335,376
2024-05-14 TECH Option Ex 4,000 22.95 91,800
2023-04-28 TECH Option Ex 16,000 21.85 349,600
2022-06-08 TECH Sale 600 366.09 219,653
2022-06-07 TECH Sale 1,000 364.31 364,310
2022-06-08 TECH Option Ex 600 66.90 40,140
2022-06-07 TECH Option Ex 1,000 66.90 66,900
2020-11-06 TECH Option Ex 5,000 70.35 351,750
2020-11-06 TECH Sale 5,000 299.96 1,499,800
2020-02-12 TECH Sale 5,000 205.23 1,026,135
2020-02-12 TECH Option Ex 5,000 61.46 307,300
2018-08-23 TECH Option Ex 10,000 61.08 610,800
2018-08-23 TECH Sale 10,000 187.92 1,879,170
2016-09-08 TECH Sale 1,700 109.83 186,716

Table 3. Insider trading of Omniab, Inc. (OABI) by Higgins John L

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-06-17 OABI Option Ex 20,000 .00 0
2025-05-12 OABI Buy 65,000 1.44 93,600
2025-03-21 OABI Buy 4,000 2.28 9,120
2025-03-20 OABI Buy 125,750 2.35 295,512
2025-01-30 OABI Option Ex 13,172 .00 0
2024-06-18 OABI Option Ex 20,000 .00 0
2024-01-30 OABI Option Ex 13,173 .00 0
2023-05-23 OABI Sale 9,000 4.05 36,450
2023-05-23 OABI Option Ex 9,000 3.68 33,120
2023-05-19 OABI Option Ex 1,000 3.68 3,680
2023-05-19 OABI Sale 1,000 4.05 4,050
2023-05-18 OABI Sale 50,000 3.89 194,500
2023-05-18 OABI Option Ex 50,000 3.68 184,000
2022-11-02 OABI Option Ex 246,648 2.52 621,552

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Higgins John L (Director of Omniab, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.